Trisomy 21 Second-trimester ultrasound

Clinics in Perinatology

Volumn 28, Issue 2, 2001, Pages 303-319

  Graupe, Menachem H ^a   Naylor, C Scott ^a   Greene, Naomi H ^a   Carlson, Dru E ^a   Platt, Lawrence ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; DOWN SYNDROME; FETUS (ANATOMY); FETUS ECHOGRAPHY; HEAD; IMAGE ANALYSIS; KARYOTYPING; LIMB; NECK; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; THORAX; TRISOMY 21;

EID: 0034909191     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70085-3     Document Type: Article

References (78)

1. Normal nuchal thickness in the midtrimester reduces risk of Down syndrome in pregnancies with abnormal triplescreen results
2. A new screening protocol combining urine beta-core fragment and ultrasonography for Down syndrome detection
3. Nuchal thickness, urine beta-core fragment level, and maternal age for Down syndrome screening
4. A high-sensitivity alternative to "routine" gemetic amniocentesis: Multiple urinary analytes, nuchal thickness and age
5. Fetal gender impact on multiple-marker screening results
6. The second-trimester fetus with Down syndrome: Detection using sonographic features
7. A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome
8. Sonographic identification of second-trimester fetuses with Down's syndrome
9. Hypoplasia of the middle phalanx of the fifth digit: A feature of the second trimester fetus with Down's syndrome
10. Fetal pyelectasis: A possible association with Down syndrome
11. Does gender have an impact on the sonographic detection of second-trimester fetuses with Down's syndrome?
12. Humeral shortening in second-trimester fetuses with Down syndrome
13. Sonographic demonstration of hypoplasia of the middle phalanx of the fifth digit: A finding associated with Down syndrome
14. Prenatal diagnosis by analysis of fetal cells in maternal blood
15. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy
16. Interobserver variability of midtrimester fetal nuchal thickness
17. Natural evolution of nuchal thickness in trisomy-21 fetuses
18. Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy
19. Choroid plexus cysts: Not associated with Down syndrome
20. Genetic sonogram scoring index: Accuracy and clinical utility
21. A role for maternal serum screening in detecting chromosomal abnormalities in fetuses with isolated choroid plexus cysts: A prospective multicentre study
22. The ultrasound triad of fetal hydramnios, abnormal hand posturing, and any other anomaly predicts autosomal trisomy
23. Obstetrical ultrasound: Assessment of fetal growth and anatomy
24. Antenatal screening for aneuploidy
25. The significance of choroid plexus cysts in an unselected population: Results of a multicenter study
26. Prenatal screening for Down's syndrome: A search for the family's values
27. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: Results of a prospective clinical trial
28. Ultrasound fetal femur length measurement in the screening for Down syndrome
29. Multiple screening for fetal Down's syndrome with the classic triple test, dimeric inhib A and ultrasound
30. Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate
31. Prospective multicenter study of second-trimester nuchal skinfold thickness in unaffected and Down syndrome Pregnancies
32. Congenital cardiovascular malformations associated with chromosome abnormalities: An epidemiologic study
33. The clinical significance of prenatally diagnosed choroid plexus cysts
34. Prenatal diagnosis of single umbilical artery: Determination of the absent side, associated anomalies, Doppler findings and perinatal outcome
35. Fifth digit measurement in normal pregnancies: A potential sonographic sign of Down's syndrome
36. Fetus-placenta-newborn: Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome
37. Antenatal screening for Down's syndrome: Where are we and where next?
38. Second-trimester echogenic small bowel: An increased risk for adverse perinatal outcome
39. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness
40. Fetal leg and femur/foot length ratio: A marker for trisomy 21
41. Noninvasive means of identifying fetuses with possible Down syndrome: A review
42. Isolated choroid plexus cyst(s): An indication for amniocentesis
43. The apparently isolated choroid plexus cyst: Importance of minor abnormalities in predicting the risk for aneuploidy
44. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome
45. A sonographic screening method for Down syndrome
46. The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters
47. Ultrasound detection of Down syndrome: Is it really possible?
48. Significance of fetal intracardiac echogenic foci in relation to trisomy 21: A prospective sonographic study of high-risk pregnant women
49. The isolated choroid plexus cyst
50. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram?
51. Value of serial sonography in the in utero detection of duodenal atresia
52. Ultrasonographically detectable markers of fetal chromosomal abnormalities
53. Humerus and femur length shortening in the detection of Down's syndrome
54. Prenatal diagnosis of congenital heart disease and fetal karyotyping
55. First-trimester diagnosis of duodenal atresia
56. Screening for Down syndrome with the femur length/biparietal diameter ratio: A new twist of the data
57. Single umbilical artery
58. Subtle ultrasonographic anomalies: Do they improve the Down syndrome detection rate
59. In utero thickening of the chordae tendinae: A cause of intracardiac echogenic foci
60. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race
61. Genetic counseling and prenatal diagnosis
62. Prognostic implications of fetal echogenic bowel
63. Femur length and trisomy 21: Impact of gestational age on screening efficiency
64. Fetal growth retardation: Associated malformations and chromosomal abnormalities
65. Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center
66. Down syndrome in the fetus
67. Fetal echogenic bowel: Parameters to be considered in differential diagnosis
68. Pathologic correlation of sonographic echogenic foci in the fetal heart
69. Chromosomal abnormalities
70. Prenatal diagnosis of Down's syndrome
71. Clinical outcome of mild fetal ventriculomegaly
72. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography
73. Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry
74. Antenatal screening for Down's syndrome
75. Fetal intracardiac echogenic foci: Current understanding and clinical significance
76. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality